Alvotech - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALVO Nasdaq 2834 www.alvotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alvotech

LOTTE Biologics and Alvotech announce US-based manufacturing agreement to increase global supply - Oct 8th, 2026 5:17 am
Alvotech (ALVO) Could Be 14% Undervalued On Manufacturing Capacity Updates - Oct 8th, 2026 5:15 am
Alvotech and LOTTE Biologics announce US-based manufacturing agreement to increase global supply - Oct 6th, 2026 2:37 pm
Alvotech Soars 13% on FDA Nod That “Effectively Doubles” US Humira Biosimilar Capacity - Oct 5th, 2026 1:14 pm
Alvotech stock surges after FDA manufacturing approval - Oct 5th, 2026 9:21 am
FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira® - Oct 5th, 2026 2:00 am
Why This Biotech Stock Just Got a Rare Double Upgrade - Sep 16th, 2026 2:25 pm
ALVO Stock Jumps On Double Upgrade — Why Barclays Sees A 59% Upside - Sep 16th, 2026 12:33 pm
Alvotech Shares Rise 5.6% After Barclays Upgrades Rating and Doubles Price Target - Sep 16th, 2026 4:53 am
Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations - Aug 31st, 2026 2:30 am
Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations - Aug 31st, 2026 2:30 am
Has Alvotech (NasdaqGM:ALVO) Fallen Below Fair Value After Its Deal? - Aug 29th, 2026 4:09 pm
Why Alvotech (ALVO) Is Up 11.7% After Expanding Biosimilar Deal With Lotus Pharmaceutical - Aug 29th, 2026 5:07 am
Bank of America sees major upside in this biotech stock - Aug 28th, 2026 12:33 pm
Alvotech to present at upcoming investor conferences in September - Aug 27th, 2026 6:00 am
Alvotech (ALVO) Gets New ‘Buy’ Reco. Should Investors Follow? - Aug 24th, 2026 5:53 pm
BofA starts bullish Alvotech coverage on biosimilar launch cycle - Aug 24th, 2026 4:41 am